Mesenchymal Stem Cell Engineered Nanovesicles for Accelerated Skin Wound Closure.

Area of Science:

• Biotechnology
• Regenerative Medicine
• Cell Biology

Background:

• Extracellular vesicles (EVs) are crucial for cell-to-cell communication.
• Mesenchymal stem cells (MSCs) are widely studied for therapeutic potential.
• Current methods for EV production have limitations in yield and characteristics.

Purpose of the Study:

• To develop and characterize novel cell-engineered nanovesicles (MSCNVs) from MSCs.
• To compare the productivity and characteristics of MSCNVs with natural EVs.
• To evaluate the therapeutic potential of MSCNVs in vitro and in vivo for regenerative applications.

Main Methods:

• Production and characterization of MSCNVs from mesenchymal stem cells.
• In vitro studies using primary skin fibroblasts to assess proliferation and migration.
• Quantitative real-time PCR to analyze growth factor expression.
• In vivo studies involving intraperitoneal injection and wound healing models in mice.

Main Results:

• MSCNVs exhibited over 300-fold higher productivity than natural EVs.
• MSCNVs shared morphological similarities with natural EVs but molecularly resembled MSCs.
• In vitro, MSCNVs significantly enhanced fibroblast proliferation and migration compared to natural EVs.
• In vivo, MSCNV treatment accelerated mouse skin wound healing, potentially via promoting angiogenesis.

Conclusions:

• MSCNVs represent a highly productive and effective cell-engineered alternative to natural EVs.
• MSCNVs demonstrate significant potential for applications in regenerative medicine, particularly in wound healing.
• Further research into MSCNVs could lead to advanced therapeutic strategies.